Evicenter
P&T meetings

Zeleciment rostudirsen (z-rostudirsen)

Duchenne muscular dystrophy

Also known as DYNE-251
Manufacturer
Dyne Therapeutics
Regulatory submission
BLA submitted May 2026
Last updated
78 sources

Product information and disease descriptionProduct description

Product information

21 evidence topics · 16 sources

Average sales price and wholesale acquisition cost

Not applicable.

Contraindications/Warnings/Precautions/Adverse effects
Warnings and precautions

Not applicable.

Drug/Drug, drug/disease interactions
Effects of other drugs on Zeleciment rostudirsen
Drug–drug, drug–food, and drug–disease interactions

No evidence found.

Effects of Zeleciment rostudirsen on other drugs

No evidence found.

Access and distribution
Commercial distribution strategy

No evidence found.

Commercial patient support program

No evidence found.